nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CYP3A4—bone cancer	0.835	1	CbGaD
Maraviroc—Eczema—Doxorubicin—bone cancer	0.00035	0.00212	CcSEcCtD
Maraviroc—Hepatic failure—Doxorubicin—bone cancer	0.00035	0.00212	CcSEcCtD
Maraviroc—Cerebrovascular accident—Epirubicin—bone cancer	0.000347	0.0021	CcSEcCtD
Maraviroc—Convulsion—Cisplatin—bone cancer	0.000345	0.00209	CcSEcCtD
Maraviroc—Renal failure acute—Doxorubicin—bone cancer	0.000341	0.00206	CcSEcCtD
Maraviroc—Myalgia—Cisplatin—bone cancer	0.000339	0.00205	CcSEcCtD
Maraviroc—Anxiety—Cisplatin—bone cancer	0.000338	0.00204	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000337	0.00204	CcSEcCtD
Maraviroc—Discomfort—Cisplatin—bone cancer	0.000335	0.00203	CcSEcCtD
Maraviroc—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000333	0.00202	CcSEcCtD
Maraviroc—Breast disorder—Methotrexate—bone cancer	0.000328	0.00198	CcSEcCtD
Maraviroc—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000327	0.00198	CcSEcCtD
Maraviroc—Purpura—Doxorubicin—bone cancer	0.000326	0.00197	CcSEcCtD
Maraviroc—Oedema—Cisplatin—bone cancer	0.000325	0.00197	CcSEcCtD
Maraviroc—Infection—Cisplatin—bone cancer	0.000323	0.00195	CcSEcCtD
Maraviroc—Cerebrovascular accident—Doxorubicin—bone cancer	0.000321	0.00194	CcSEcCtD
Maraviroc—Nervous system disorder—Cisplatin—bone cancer	0.000319	0.00193	CcSEcCtD
Maraviroc—Skin disorder—Cisplatin—bone cancer	0.000316	0.00191	CcSEcCtD
Maraviroc—Eosinophilia—Methotrexate—bone cancer	0.000311	0.00188	CcSEcCtD
Maraviroc—Abdominal pain upper—Epirubicin—bone cancer	0.000311	0.00188	CcSEcCtD
Maraviroc—Orthostatic hypotension—Epirubicin—bone cancer	0.000311	0.00188	CcSEcCtD
Maraviroc—Anorexia—Cisplatin—bone cancer	0.00031	0.00188	CcSEcCtD
Maraviroc—Pancreatitis—Methotrexate—bone cancer	0.000308	0.00186	CcSEcCtD
Maraviroc—Breast disorder—Epirubicin—bone cancer	0.000307	0.00186	CcSEcCtD
Maraviroc—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000306	0.00185	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000306	0.00185	CcSEcCtD
Maraviroc—Nasopharyngitis—Epirubicin—bone cancer	0.000304	0.00184	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Epirubicin—bone cancer	0.0003	0.00181	CcSEcCtD
Maraviroc—Pancytopenia—Methotrexate—bone cancer	0.000298	0.0018	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000296	0.00179	CcSEcCtD
Maraviroc—Abdominal distension—Epirubicin—bone cancer	0.000296	0.00179	CcSEcCtD
Maraviroc—Influenza—Epirubicin—bone cancer	0.000294	0.00178	CcSEcCtD
Maraviroc—Neutropenia—Methotrexate—bone cancer	0.000294	0.00177	CcSEcCtD
Maraviroc—Paraesthesia—Cisplatin—bone cancer	0.000292	0.00177	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Methotrexate—bone cancer	0.000292	0.00176	CcSEcCtD
Maraviroc—Eosinophilia—Epirubicin—bone cancer	0.000291	0.00176	CcSEcCtD
Maraviroc—Pancreatitis—Epirubicin—bone cancer	0.000288	0.00174	CcSEcCtD
Maraviroc—Abdominal pain upper—Doxorubicin—bone cancer	0.000287	0.00174	CcSEcCtD
Maraviroc—Orthostatic hypotension—Doxorubicin—bone cancer	0.000287	0.00174	CcSEcCtD
Maraviroc—Angina pectoris—Epirubicin—bone cancer	0.000286	0.00173	CcSEcCtD
Maraviroc—Breast disorder—Doxorubicin—bone cancer	0.000284	0.00172	CcSEcCtD
Maraviroc—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000283	0.00171	CcSEcCtD
Maraviroc—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000283	0.00171	CcSEcCtD
Maraviroc—Decreased appetite—Cisplatin—bone cancer	0.000283	0.00171	CcSEcCtD
Maraviroc—Bronchitis—Epirubicin—bone cancer	0.000283	0.00171	CcSEcCtD
Maraviroc—Pneumonia—Methotrexate—bone cancer	0.000282	0.0017	CcSEcCtD
Maraviroc—Nasopharyngitis—Doxorubicin—bone cancer	0.000281	0.0017	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Cisplatin—bone cancer	0.000281	0.0017	CcSEcCtD
Maraviroc—Infestation NOS—Methotrexate—bone cancer	0.00028	0.00169	CcSEcCtD
Maraviroc—Infestation—Methotrexate—bone cancer	0.00028	0.00169	CcSEcCtD
Maraviroc—Depression—Methotrexate—bone cancer	0.000279	0.00169	CcSEcCtD
Maraviroc—Pancytopenia—Epirubicin—bone cancer	0.000279	0.00169	CcSEcCtD
Maraviroc—Pain—Cisplatin—bone cancer	0.000278	0.00168	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000278	0.00168	CcSEcCtD
Maraviroc—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000277	0.00168	CcSEcCtD
Maraviroc—Renal failure—Methotrexate—bone cancer	0.000275	0.00166	CcSEcCtD
Maraviroc—Neutropenia—Epirubicin—bone cancer	0.000275	0.00166	CcSEcCtD
Maraviroc—Abdominal distension—Doxorubicin—bone cancer	0.000274	0.00165	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Epirubicin—bone cancer	0.000273	0.00165	CcSEcCtD
Maraviroc—Stomatitis—Methotrexate—bone cancer	0.000273	0.00165	CcSEcCtD
Maraviroc—Conjunctivitis—Methotrexate—bone cancer	0.000272	0.00165	CcSEcCtD
Maraviroc—Influenza—Doxorubicin—bone cancer	0.000272	0.00164	CcSEcCtD
Maraviroc—Eosinophilia—Doxorubicin—bone cancer	0.000269	0.00163	CcSEcCtD
Maraviroc—Pancreatitis—Doxorubicin—bone cancer	0.000267	0.00161	CcSEcCtD
Maraviroc—Angina pectoris—Doxorubicin—bone cancer	0.000265	0.0016	CcSEcCtD
Maraviroc—Hepatobiliary disease—Methotrexate—bone cancer	0.000265	0.0016	CcSEcCtD
Maraviroc—Pneumonia—Epirubicin—bone cancer	0.000264	0.00159	CcSEcCtD
Maraviroc—Infestation NOS—Epirubicin—bone cancer	0.000262	0.00158	CcSEcCtD
Maraviroc—Infestation—Epirubicin—bone cancer	0.000262	0.00158	CcSEcCtD
Maraviroc—Bronchitis—Doxorubicin—bone cancer	0.000261	0.00158	CcSEcCtD
Maraviroc—Agranulocytosis—Methotrexate—bone cancer	0.000261	0.00158	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00026	0.00157	CcSEcCtD
Maraviroc—Pancytopenia—Doxorubicin—bone cancer	0.000258	0.00156	CcSEcCtD
Maraviroc—Renal failure—Epirubicin—bone cancer	0.000258	0.00156	CcSEcCtD
Maraviroc—Body temperature increased—Cisplatin—bone cancer	0.000257	0.00156	CcSEcCtD
Maraviroc—Neuropathy peripheral—Epirubicin—bone cancer	0.000257	0.00155	CcSEcCtD
Maraviroc—Jaundice—Epirubicin—bone cancer	0.000255	0.00154	CcSEcCtD
Maraviroc—Stomatitis—Epirubicin—bone cancer	0.000255	0.00154	CcSEcCtD
Maraviroc—Conjunctivitis—Epirubicin—bone cancer	0.000255	0.00154	CcSEcCtD
Maraviroc—Neutropenia—Doxorubicin—bone cancer	0.000254	0.00154	CcSEcCtD
Maraviroc—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000253	0.00153	CcSEcCtD
Maraviroc—Pharyngitis—Methotrexate—bone cancer	0.000249	0.00151	CcSEcCtD
Maraviroc—Urinary tract disorder—Methotrexate—bone cancer	0.000248	0.0015	CcSEcCtD
Maraviroc—Hepatobiliary disease—Epirubicin—bone cancer	0.000248	0.0015	CcSEcCtD
Maraviroc—Urethral disorder—Methotrexate—bone cancer	0.000246	0.00149	CcSEcCtD
Maraviroc—Sinusitis—Epirubicin—bone cancer	0.000246	0.00149	CcSEcCtD
Maraviroc—Agranulocytosis—Epirubicin—bone cancer	0.000244	0.00148	CcSEcCtD
Maraviroc—Pneumonia—Doxorubicin—bone cancer	0.000244	0.00147	CcSEcCtD
Maraviroc—Infestation NOS—Doxorubicin—bone cancer	0.000242	0.00147	CcSEcCtD
Maraviroc—Infestation—Doxorubicin—bone cancer	0.000242	0.00147	CcSEcCtD
Maraviroc—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00024	0.00145	CcSEcCtD
Maraviroc—Hypersensitivity—Cisplatin—bone cancer	0.00024	0.00145	CcSEcCtD
Maraviroc—Renal failure—Doxorubicin—bone cancer	0.000238	0.00144	CcSEcCtD
Maraviroc—Erythema multiforme—Methotrexate—bone cancer	0.000238	0.00144	CcSEcCtD
Maraviroc—Neuropathy peripheral—Doxorubicin—bone cancer	0.000238	0.00144	CcSEcCtD
Maraviroc—Jaundice—Doxorubicin—bone cancer	0.000236	0.00143	CcSEcCtD
Maraviroc—Stomatitis—Doxorubicin—bone cancer	0.000236	0.00143	CcSEcCtD
Maraviroc—Rhinitis—Epirubicin—bone cancer	0.000236	0.00143	CcSEcCtD
Maraviroc—Conjunctivitis—Doxorubicin—bone cancer	0.000236	0.00142	CcSEcCtD
Maraviroc—Eye disorder—Methotrexate—bone cancer	0.000235	0.00142	CcSEcCtD
Maraviroc—Asthenia—Cisplatin—bone cancer	0.000233	0.00141	CcSEcCtD
Maraviroc—Pharyngitis—Epirubicin—bone cancer	0.000233	0.00141	CcSEcCtD
Maraviroc—Cardiac disorder—Methotrexate—bone cancer	0.000233	0.00141	CcSEcCtD
Maraviroc—Urinary tract disorder—Epirubicin—bone cancer	0.000232	0.0014	CcSEcCtD
Maraviroc—Connective tissue disorder—Epirubicin—bone cancer	0.000231	0.0014	CcSEcCtD
Maraviroc—Urethral disorder—Epirubicin—bone cancer	0.000231	0.00139	CcSEcCtD
Maraviroc—Hepatobiliary disease—Doxorubicin—bone cancer	0.000229	0.00139	CcSEcCtD
Maraviroc—Angiopathy—Methotrexate—bone cancer	0.000228	0.00138	CcSEcCtD
Maraviroc—Sinusitis—Doxorubicin—bone cancer	0.000227	0.00137	CcSEcCtD
Maraviroc—Mediastinal disorder—Methotrexate—bone cancer	0.000226	0.00137	CcSEcCtD
Maraviroc—Agranulocytosis—Doxorubicin—bone cancer	0.000226	0.00137	CcSEcCtD
Maraviroc—Diarrhoea—Cisplatin—bone cancer	0.000223	0.00135	CcSEcCtD
Maraviroc—Erythema multiforme—Epirubicin—bone cancer	0.000222	0.00134	CcSEcCtD
Maraviroc—Alopecia—Methotrexate—bone cancer	0.000222	0.00134	CcSEcCtD
Maraviroc—Mental disorder—Methotrexate—bone cancer	0.00022	0.00133	CcSEcCtD
Maraviroc—Eye disorder—Epirubicin—bone cancer	0.00022	0.00133	CcSEcCtD
Maraviroc—Malnutrition—Methotrexate—bone cancer	0.000219	0.00132	CcSEcCtD
Maraviroc—Erythema—Methotrexate—bone cancer	0.000219	0.00132	CcSEcCtD
Maraviroc—Cardiac disorder—Epirubicin—bone cancer	0.000218	0.00132	CcSEcCtD
Maraviroc—Rhinitis—Doxorubicin—bone cancer	0.000218	0.00132	CcSEcCtD
Maraviroc—Pharyngitis—Doxorubicin—bone cancer	0.000216	0.00131	CcSEcCtD
Maraviroc—Urinary tract disorder—Doxorubicin—bone cancer	0.000215	0.0013	CcSEcCtD
Maraviroc—Connective tissue disorder—Doxorubicin—bone cancer	0.000214	0.00129	CcSEcCtD
Maraviroc—Angiopathy—Epirubicin—bone cancer	0.000213	0.00129	CcSEcCtD
Maraviroc—Urethral disorder—Doxorubicin—bone cancer	0.000213	0.00129	CcSEcCtD
Maraviroc—Mediastinal disorder—Epirubicin—bone cancer	0.000212	0.00128	CcSEcCtD
Maraviroc—Alopecia—Epirubicin—bone cancer	0.000208	0.00126	CcSEcCtD
Maraviroc—Vomiting—Cisplatin—bone cancer	0.000207	0.00125	CcSEcCtD
Maraviroc—Mental disorder—Epirubicin—bone cancer	0.000206	0.00125	CcSEcCtD
Maraviroc—Erythema multiforme—Doxorubicin—bone cancer	0.000206	0.00124	CcSEcCtD
Maraviroc—Rash—Cisplatin—bone cancer	0.000205	0.00124	CcSEcCtD
Maraviroc—Dermatitis—Cisplatin—bone cancer	0.000205	0.00124	CcSEcCtD
Maraviroc—Malnutrition—Epirubicin—bone cancer	0.000205	0.00124	CcSEcCtD
Maraviroc—Erythema—Epirubicin—bone cancer	0.000205	0.00124	CcSEcCtD
Maraviroc—Eye disorder—Doxorubicin—bone cancer	0.000203	0.00123	CcSEcCtD
Maraviroc—Anaemia—Methotrexate—bone cancer	0.000202	0.00122	CcSEcCtD
Maraviroc—Cardiac disorder—Doxorubicin—bone cancer	0.000202	0.00122	CcSEcCtD
Maraviroc—Flatulence—Epirubicin—bone cancer	0.000202	0.00122	CcSEcCtD
Maraviroc—Angiopathy—Doxorubicin—bone cancer	0.000197	0.00119	CcSEcCtD
Maraviroc—Mediastinal disorder—Doxorubicin—bone cancer	0.000196	0.00119	CcSEcCtD
Maraviroc—Leukopenia—Methotrexate—bone cancer	0.000196	0.00118	CcSEcCtD
Maraviroc—Nausea—Cisplatin—bone cancer	0.000193	0.00117	CcSEcCtD
Maraviroc—Alopecia—Doxorubicin—bone cancer	0.000192	0.00116	CcSEcCtD
Maraviroc—Cough—Methotrexate—bone cancer	0.000191	0.00115	CcSEcCtD
Maraviroc—Mental disorder—Doxorubicin—bone cancer	0.000191	0.00115	CcSEcCtD
Maraviroc—Convulsion—Methotrexate—bone cancer	0.00019	0.00115	CcSEcCtD
Maraviroc—Erythema—Doxorubicin—bone cancer	0.000189	0.00115	CcSEcCtD
Maraviroc—Malnutrition—Doxorubicin—bone cancer	0.000189	0.00115	CcSEcCtD
Maraviroc—Anaemia—Epirubicin—bone cancer	0.000189	0.00114	CcSEcCtD
Maraviroc—Flatulence—Doxorubicin—bone cancer	0.000187	0.00113	CcSEcCtD
Maraviroc—Myalgia—Methotrexate—bone cancer	0.000186	0.00113	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000185	0.00112	CcSEcCtD
Maraviroc—Discomfort—Methotrexate—bone cancer	0.000184	0.00111	CcSEcCtD
Maraviroc—Syncope—Epirubicin—bone cancer	0.000184	0.00111	CcSEcCtD
Maraviroc—Leukopenia—Epirubicin—bone cancer	0.000183	0.00111	CcSEcCtD
Maraviroc—Loss of consciousness—Epirubicin—bone cancer	0.00018	0.00109	CcSEcCtD
Maraviroc—Cough—Epirubicin—bone cancer	0.000179	0.00108	CcSEcCtD
Maraviroc—Convulsion—Epirubicin—bone cancer	0.000177	0.00107	CcSEcCtD
Maraviroc—Infection—Methotrexate—bone cancer	0.000177	0.00107	CcSEcCtD
Maraviroc—Nervous system disorder—Methotrexate—bone cancer	0.000175	0.00106	CcSEcCtD
Maraviroc—Anaemia—Doxorubicin—bone cancer	0.000175	0.00106	CcSEcCtD
Maraviroc—Myalgia—Epirubicin—bone cancer	0.000174	0.00105	CcSEcCtD
Maraviroc—Anxiety—Epirubicin—bone cancer	0.000174	0.00105	CcSEcCtD
Maraviroc—Skin disorder—Methotrexate—bone cancer	0.000173	0.00105	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000173	0.00105	CcSEcCtD
Maraviroc—Discomfort—Epirubicin—bone cancer	0.000172	0.00104	CcSEcCtD
Maraviroc—Anorexia—Methotrexate—bone cancer	0.00017	0.00103	CcSEcCtD
Maraviroc—Syncope—Doxorubicin—bone cancer	0.00017	0.00103	CcSEcCtD
Maraviroc—Leukopenia—Doxorubicin—bone cancer	0.00017	0.00103	CcSEcCtD
Maraviroc—Oedema—Epirubicin—bone cancer	0.000167	0.00101	CcSEcCtD
Maraviroc—Loss of consciousness—Doxorubicin—bone cancer	0.000166	0.00101	CcSEcCtD
Maraviroc—Infection—Epirubicin—bone cancer	0.000166	0.001	CcSEcCtD
Maraviroc—Cough—Doxorubicin—bone cancer	0.000165	0.000999	CcSEcCtD
Maraviroc—Shock—Epirubicin—bone cancer	0.000164	0.000994	CcSEcCtD
Maraviroc—Convulsion—Doxorubicin—bone cancer	0.000164	0.000992	CcSEcCtD
Maraviroc—Nervous system disorder—Epirubicin—bone cancer	0.000164	0.000991	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000163	0.000983	CcSEcCtD
Maraviroc—Skin disorder—Epirubicin—bone cancer	0.000162	0.000981	CcSEcCtD
Maraviroc—Insomnia—Methotrexate—bone cancer	0.000161	0.000976	CcSEcCtD
Maraviroc—Myalgia—Doxorubicin—bone cancer	0.000161	0.000975	CcSEcCtD
Maraviroc—Anxiety—Doxorubicin—bone cancer	0.000161	0.000972	CcSEcCtD
Maraviroc—Paraesthesia—Methotrexate—bone cancer	0.00016	0.000969	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00016	0.000968	CcSEcCtD
Maraviroc—Discomfort—Doxorubicin—bone cancer	0.000159	0.000963	CcSEcCtD
Maraviroc—Anorexia—Epirubicin—bone cancer	0.000159	0.000963	CcSEcCtD
Maraviroc—Decreased appetite—Methotrexate—bone cancer	0.000155	0.000938	CcSEcCtD
Maraviroc—Oedema—Doxorubicin—bone cancer	0.000155	0.000935	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Methotrexate—bone cancer	0.000154	0.000932	CcSEcCtD
Maraviroc—Fatigue—Methotrexate—bone cancer	0.000154	0.000931	CcSEcCtD
Maraviroc—Infection—Doxorubicin—bone cancer	0.000154	0.000929	CcSEcCtD
Maraviroc—Pain—Methotrexate—bone cancer	0.000153	0.000923	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000152	0.00092	CcSEcCtD
Maraviroc—Shock—Doxorubicin—bone cancer	0.000152	0.00092	CcSEcCtD
Maraviroc—Nervous system disorder—Doxorubicin—bone cancer	0.000152	0.000917	CcSEcCtD
Maraviroc—Insomnia—Epirubicin—bone cancer	0.000151	0.000914	CcSEcCtD
Maraviroc—Skin disorder—Doxorubicin—bone cancer	0.00015	0.000908	CcSEcCtD
Maraviroc—Paraesthesia—Epirubicin—bone cancer	0.00015	0.000907	CcSEcCtD
Maraviroc—Anorexia—Doxorubicin—bone cancer	0.000147	0.000891	CcSEcCtD
Maraviroc—Gastrointestinal pain—Methotrexate—bone cancer	0.000146	0.000883	CcSEcCtD
Maraviroc—Decreased appetite—Epirubicin—bone cancer	0.000145	0.000878	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Epirubicin—bone cancer	0.000144	0.000872	CcSEcCtD
Maraviroc—Fatigue—Epirubicin—bone cancer	0.000144	0.000871	CcSEcCtD
Maraviroc—Pain—Epirubicin—bone cancer	0.000143	0.000864	CcSEcCtD
Maraviroc—Constipation—Epirubicin—bone cancer	0.000143	0.000864	CcSEcCtD
Maraviroc—Abdominal pain—Methotrexate—bone cancer	0.000141	0.000853	CcSEcCtD
Maraviroc—Body temperature increased—Methotrexate—bone cancer	0.000141	0.000853	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000141	0.000852	CcSEcCtD
Maraviroc—Insomnia—Doxorubicin—bone cancer	0.00014	0.000845	CcSEcCtD
Maraviroc—Paraesthesia—Doxorubicin—bone cancer	0.000139	0.000839	CcSEcCtD
Maraviroc—Gastrointestinal pain—Epirubicin—bone cancer	0.000137	0.000826	CcSEcCtD
Maraviroc—Decreased appetite—Doxorubicin—bone cancer	0.000134	0.000813	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000133	0.000807	CcSEcCtD
Maraviroc—Fatigue—Doxorubicin—bone cancer	0.000133	0.000806	CcSEcCtD
Maraviroc—Pain—Doxorubicin—bone cancer	0.000132	0.000799	CcSEcCtD
Maraviroc—Constipation—Doxorubicin—bone cancer	0.000132	0.000799	CcSEcCtD
Maraviroc—Body temperature increased—Epirubicin—bone cancer	0.000132	0.000799	CcSEcCtD
Maraviroc—Abdominal pain—Epirubicin—bone cancer	0.000132	0.000799	CcSEcCtD
Maraviroc—Hypersensitivity—Methotrexate—bone cancer	0.000132	0.000795	CcSEcCtD
Maraviroc—Asthenia—Methotrexate—bone cancer	0.000128	0.000774	CcSEcCtD
Maraviroc—Gastrointestinal pain—Doxorubicin—bone cancer	0.000126	0.000764	CcSEcCtD
Maraviroc—Pruritus—Methotrexate—bone cancer	0.000126	0.000764	CcSEcCtD
Maraviroc—Hypersensitivity—Epirubicin—bone cancer	0.000123	0.000744	CcSEcCtD
Maraviroc—Abdominal pain—Doxorubicin—bone cancer	0.000122	0.000739	CcSEcCtD
Maraviroc—Body temperature increased—Doxorubicin—bone cancer	0.000122	0.000739	CcSEcCtD
Maraviroc—Diarrhoea—Methotrexate—bone cancer	0.000122	0.000739	CcSEcCtD
Maraviroc—Asthenia—Epirubicin—bone cancer	0.00012	0.000725	CcSEcCtD
Maraviroc—Pruritus—Epirubicin—bone cancer	0.000118	0.000715	CcSEcCtD
Maraviroc—Dizziness—Methotrexate—bone cancer	0.000118	0.000714	CcSEcCtD
Maraviroc—Diarrhoea—Epirubicin—bone cancer	0.000114	0.000691	CcSEcCtD
Maraviroc—Hypersensitivity—Doxorubicin—bone cancer	0.000114	0.000689	CcSEcCtD
Maraviroc—Vomiting—Methotrexate—bone cancer	0.000114	0.000686	CcSEcCtD
Maraviroc—Rash—Methotrexate—bone cancer	0.000113	0.000681	CcSEcCtD
Maraviroc—Dermatitis—Methotrexate—bone cancer	0.000112	0.00068	CcSEcCtD
Maraviroc—Headache—Methotrexate—bone cancer	0.000112	0.000676	CcSEcCtD
Maraviroc—Asthenia—Doxorubicin—bone cancer	0.000111	0.000671	CcSEcCtD
Maraviroc—Dizziness—Epirubicin—bone cancer	0.00011	0.000668	CcSEcCtD
Maraviroc—Pruritus—Doxorubicin—bone cancer	0.000109	0.000661	CcSEcCtD
Maraviroc—Vomiting—Epirubicin—bone cancer	0.000106	0.000642	CcSEcCtD
Maraviroc—Nausea—Methotrexate—bone cancer	0.000106	0.000641	CcSEcCtD
Maraviroc—Diarrhoea—Doxorubicin—bone cancer	0.000106	0.00064	CcSEcCtD
Maraviroc—Rash—Epirubicin—bone cancer	0.000105	0.000637	CcSEcCtD
Maraviroc—Dermatitis—Epirubicin—bone cancer	0.000105	0.000636	CcSEcCtD
Maraviroc—Headache—Epirubicin—bone cancer	0.000105	0.000633	CcSEcCtD
Maraviroc—Dizziness—Doxorubicin—bone cancer	0.000102	0.000618	CcSEcCtD
Maraviroc—Nausea—Epirubicin—bone cancer	9.93e-05	0.0006	CcSEcCtD
Maraviroc—Vomiting—Doxorubicin—bone cancer	9.83e-05	0.000594	CcSEcCtD
Maraviroc—Rash—Doxorubicin—bone cancer	9.75e-05	0.000589	CcSEcCtD
Maraviroc—Dermatitis—Doxorubicin—bone cancer	9.74e-05	0.000589	CcSEcCtD
Maraviroc—Headache—Doxorubicin—bone cancer	9.69e-05	0.000586	CcSEcCtD
Maraviroc—Nausea—Doxorubicin—bone cancer	9.18e-05	0.000555	CcSEcCtD
